The effect of statins on rate of cognitive decline in mild cognitive impairment

Abstract

This study's aims are to identify whether a relationship between statin use and rate of cognitive decline exists. The relationship between statins and mild cognitive impairment (MCI) has been investigated in the past with the evidence showing mixed results.

Document Details

• Document Type: Pub Defense Publication
• Publication Date: Feb 09, 2017
• Source ID: 10.1016/j.trci.2017.01.001

Entities

People

• Kyle B. Smith
• Marwan N. Sabbagh
• Paul Kang
• The Alzheimer’s Disease Neuroimaging Initiative*

Organizations

• Barrow Neurological Institute
• BioClinica
• Canadian Institutes of Health Research
• GE HealthCare
• Laboratoires Servier
• Lundbeck
• Merck & Co.
• National Institute on Aging
• National Institutes of Health
• Northern California Institute for Research and Education
• Roche (United States)
• Takeda Pharmaceutical Company
• United States Department of Defense
• University of Arizona

Tags

Fields of Study

• Psychology

Readers

• Mathematics or Statistics
• Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.